0001465818-22-000003.txt : 20220401 0001465818-22-000003.hdr.sgml : 20220401 20220331200213 ACCESSION NUMBER: 0001465818-22-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220401 DATE AS OF CHANGE: 20220331 EFFECTIVENESS DATE: 20220401 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Edoc Acquisition Corp. CENTRAL INDEX KEY: 0001824884 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-440003 FILM NUMBER: 22795150 BUSINESS ADDRESS: STREET 1: 7612 MAIN STREET FISHERS STREET 2: SUITE 200 CITY: VICTOR STATE: NY ZIP: 14564 BUSINESS PHONE: 5856781198 MAIL ADDRESS: STREET 1: 7612 MAIN STREET FISHERS STREET 2: SUITE 200 CITY: VICTOR STATE: NY ZIP: 14564 D 1 primary_doc.xml X0708 D LIVE 0001824884 Edoc Acquisition Corp. 7612 MAIN STREET FISHERS SUITE 200 VICTOR NY NEW YORK 14564 5856781198 CAYMAN ISLANDS None None Corporation true 2020 Kevin Chen 7612 Main Street Fishers, Suite 200 Victor NY NEW YORK 14564 Executive Officer Director Christine Zhao 7612 Main Street Fishers, Suite 200 Victor NY NEW YORK 14564 Executive Officer Director Bob Ai 7612 Main Street Fishers, Suite 200 Victor NY NEW YORK 14564 Director Gang Li 7612 Main Street Fishers, Suite 200 Victor NY NEW YORK 14564 Director Jiuji Yan 7612 Main Street Fishers, Suite 200 Victor NY NEW YORK 14564 Director Other Decline to Disclose 06b false true false true true $75 million common stock purchase agreement is conditioned upon the completion of a merger agreement with Calidi Biotherapeutics, Inc. and an effective registration statement. 0 75000000 0 75000000 150,000 shares will be issued to the investor as consideration for commitment to purchase up to $75 million shares of common stock. false 0 0 0 0 false Edoc Acquisition Corp. /s/ Kevin Chen Kevin Chen Chief Executive Officer 2022-03-31